AR012217A1 - Una composicion topica para mejorar la penetracion de compuestos farmaceuticos - Google Patents
Una composicion topica para mejorar la penetracion de compuestos farmaceuticosInfo
- Publication number
- AR012217A1 AR012217A1 ARP980101461A ARP980101461A AR012217A1 AR 012217 A1 AR012217 A1 AR 012217A1 AR P980101461 A ARP980101461 A AR P980101461A AR P980101461 A ARP980101461 A AR P980101461A AR 012217 A1 AR012217 A1 AR 012217A1
- Authority
- AR
- Argentina
- Prior art keywords
- penetration
- topical composition
- improve
- composition
- pharmaceutical compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000035515 penetration Effects 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- 239000002904 solvent Substances 0.000 abstract 4
- 239000007853 buffer solution Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000000872 buffer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82909197A | 1997-03-31 | 1997-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012217A1 true AR012217A1 (es) | 2000-09-27 |
Family
ID=25253504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980101461A AR012217A1 (es) | 1997-03-31 | 1998-03-31 | Una composicion topica para mejorar la penetracion de compuestos farmaceuticos |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0971746A1 (fr) |
| JP (1) | JP2001518879A (fr) |
| KR (1) | KR19980081207A (fr) |
| CN (1) | CN1252003A (fr) |
| AR (1) | AR012217A1 (fr) |
| AU (1) | AU6677698A (fr) |
| BR (1) | BR9811458A (fr) |
| CA (1) | CA2285368A1 (fr) |
| CO (1) | CO5050328A1 (fr) |
| HU (1) | HUP0001739A3 (fr) |
| IL (1) | IL132096A0 (fr) |
| PL (1) | PL335934A1 (fr) |
| WO (1) | WO1998043673A1 (fr) |
| ZA (1) | ZA982662B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2232855C (fr) * | 1997-04-10 | 2007-10-09 | Roche Consumer Health (Worldwide) Sa | Preparation pharmaceutique |
| AU5146600A (en) * | 1999-05-27 | 2000-12-18 | Procter & Gamble Company, The | Topical compositions providing improved treatment of skin or scalp fungal infections |
| GB0103046D0 (en) | 2001-02-07 | 2001-03-21 | Novartis Ag | Organic Compounds |
| IL142037A0 (en) * | 2001-03-15 | 2002-03-10 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug |
| MY129350A (en) * | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
| JP5435836B2 (ja) * | 2003-07-03 | 2014-03-05 | 大正製薬株式会社 | 外用抗真菌剤組成物 |
| JP4784051B2 (ja) * | 2003-07-03 | 2011-09-28 | 大正製薬株式会社 | 容器への吸着を防止した外用抗真菌組成物 |
| DE102005059742A1 (de) | 2005-12-13 | 2007-06-14 | Beiersdorf Ag | Transparentes Sonnenschutzmittel |
| US20080032994A1 (en) | 2006-08-03 | 2008-02-07 | Marcel Borgers | Modified azole compounds as antifungal and antibacterial agents |
| DK2079441T3 (da) * | 2007-07-25 | 2010-12-13 | Ixodes Gmbh | Topisk antibiotisk sammensætning til forebyggelse af Lyme's sygdom |
| JP5313905B2 (ja) * | 2007-08-27 | 2013-10-09 | 日本農薬株式会社 | 真菌性皮膚炎用剤 |
| US20090175810A1 (en) | 2008-01-03 | 2009-07-09 | Gareth Winckle | Compositions and methods for treating diseases of the nail |
| US8039494B1 (en) | 2010-07-08 | 2011-10-18 | Dow Pharmaceutical Sciences, Inc. | Compositions and methods for treating diseases of the nail |
| US9839611B2 (en) * | 2013-09-10 | 2017-12-12 | Insys Development Company, Inc. | Sublingual buprenorphine spray |
| SG11201602596UA (en) | 2013-10-03 | 2016-04-28 | Dow Pharmaceutical Sciences | Stabilized efinaconazole compositions |
| EP3071295A4 (fr) | 2013-11-22 | 2017-05-31 | Dow Pharmaceutical Sciences, Inc. | Procédés, compositions et dispositifs anti-infectieux |
| CN115745757B (zh) * | 2022-11-07 | 2024-04-26 | 中国人民解放军军事科学院军事医学研究院 | 一种液态多甘醇柱芳烃衍生物的合成及对经皮药效分子缓释的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT89837B (pt) * | 1988-02-29 | 1994-01-31 | Pfizer | Processo para a preparacao de composicoes para aumentar o fluxo transdermico contendo uma 1-alquilazaciclo-heptan-2-ona ou uma cis-olefina |
| GB8827822D0 (en) * | 1988-11-29 | 1988-12-29 | Janssen Pharmaceutica Nv | (1h-azol-1-ylmethyl)substituted quinoline derivatives |
| CN1106259A (zh) * | 1994-02-05 | 1995-08-09 | 日东制药株式会社 | 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂 |
-
1998
- 1998-03-03 CA CA002285368A patent/CA2285368A1/fr not_active Abandoned
- 1998-03-03 PL PL98335934A patent/PL335934A1/xx unknown
- 1998-03-03 AU AU66776/98A patent/AU6677698A/en not_active Abandoned
- 1998-03-03 EP EP98908843A patent/EP0971746A1/fr not_active Withdrawn
- 1998-03-03 HU HU0001739A patent/HUP0001739A3/hu unknown
- 1998-03-03 JP JP54163598A patent/JP2001518879A/ja active Pending
- 1998-03-03 BR BR9811458-1A patent/BR9811458A/pt not_active Application Discontinuation
- 1998-03-03 CN CN98803908A patent/CN1252003A/zh active Pending
- 1998-03-03 IL IL13209698A patent/IL132096A0/xx unknown
- 1998-03-03 WO PCT/US1998/004033 patent/WO1998043673A1/fr not_active Application Discontinuation
- 1998-03-30 ZA ZA9802662A patent/ZA982662B/xx unknown
- 1998-03-31 AR ARP980101461A patent/AR012217A1/es unknown
- 1998-03-31 CO CO98017937A patent/CO5050328A1/es unknown
- 1998-03-31 KR KR1019980012493A patent/KR19980081207A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1252003A (zh) | 2000-05-03 |
| CO5050328A1 (es) | 2001-06-27 |
| HUP0001739A3 (en) | 2001-04-28 |
| EP0971746A1 (fr) | 2000-01-19 |
| WO1998043673A1 (fr) | 1998-10-08 |
| AU6677698A (en) | 1998-10-22 |
| CA2285368A1 (fr) | 1998-10-08 |
| KR19980081207A (ko) | 1998-11-25 |
| HUP0001739A2 (hu) | 2000-12-28 |
| PL335934A1 (en) | 2000-05-22 |
| IL132096A0 (en) | 2001-03-19 |
| BR9811458A (pt) | 2000-09-19 |
| JP2001518879A (ja) | 2001-10-16 |
| ZA982662B (en) | 1999-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR012217A1 (es) | Una composicion topica para mejorar la penetracion de compuestos farmaceuticos | |
| ES2526912T3 (es) | Composición farmacéutica que contiene neurotoxina botulínica A2 | |
| BR0313343A (pt) | Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal | |
| SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
| AR033342A1 (es) | Una composicion otica topica o intranasal para tratar el dolor otico y el uso topico de agonistas de opioides kapa para tratar el dolor otico | |
| MX9202407A (es) | Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion. | |
| AR002007A1 (es) | UNA COMPOSICION TERAPEUTICA DE APLICACION TOPICA QUE CONTIENE UN ANTAGONISTA DE SUSTANCIA P Y UTILIZACION DE DICHO ANTAGONISTA PARA LAPREPARACIóN DE DICHA COMPOSICION PARA DISMINUIR Y/O ELIMINAR UN EFECTO SECUNDARIO IRRITANTE DE UN PRODUCTO CONTENIDO EN LA MISMA. | |
| TR199800631A2 (xx) | Ecza form�lasyonu. | |
| DK1187601T3 (da) | Hidtil ukendt præparat og administrationsform som omfatter en syrelabil protonpumpeinhibitor | |
| BR9712304A (pt) | Uso de derivados de pirazol1-benzil-3-(hetarila substituìda)-fundidos | |
| CL2008003941A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden compulsivo obsesivo. | |
| AR003176A1 (es) | Una composicion farmaceutica para inhibir el crecimiento de cancer | |
| BR9812148A (pt) | Derivados de eritromicina 6,9-ligados em ponte | |
| ATE339224T1 (de) | Honig enthaltende pharmazeutische zusammensetzung zur wundbehandlung | |
| ECSP930933A (es) | Composicion farmaceutica y procedimiento para prepararla | |
| AR000357A1 (es) | Utilización de un antagonista de sustancia p para la preparación de una composición farmacéutica de aplicación topica para tratar las manchas rojas cutaneas de origen neurogeno y especialmente la rosacea y el eritema pudico | |
| PA8515601A1 (es) | El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos | |
| AR030957A1 (es) | Composiciones de analgesico y glucosamina | |
| AR052882A1 (es) | Composicion antihelmintica | |
| UY26171A1 (es) | Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía | |
| AR001247A1 (es) | Preparados en forma de parches para el tratamientode plantas y métodos para aplicar agentes agroquímicos a plantas | |
| ES2180751T3 (es) | Inhibidor de metastasis de cancer. | |
| AR033596A1 (es) | Composicion farmaceutica para inyeccion intramuscular que contiene loxoprofeno | |
| ATE259638T1 (de) | Nicht-festes topisch anzuwendendes arzneimittel enthaltend glyzerol und alchemilla vulgaris extrakt | |
| ES2150404T3 (es) | Composiciones farmaceuticas de tizoxanida y nitozoxanida. |